{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T16:07:46Z","timestamp":1693238866661},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.diagmicrobio.2012.04.003","type":"journal-article","created":{"date-parts":[[2012,5,8]],"date-time":"2012-05-08T12:17:15Z","timestamp":1336479435000},"page":"287-289","source":"Crossref","is-referenced-by-count":8,"title":["Activity of telavancin compared to other agents against coagulase-negative staphylococci with different resistotypes by time kill"],"prefix":"10.1016","volume":"73","author":[{"given":"Gengrong","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn A.","family":"Pankuch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter C.","family":"Appelbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaudia","family":"Kosowska-Shick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2012.04.003_bb0070","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard - eighth edition, M07-A8","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2009"},{"key":"10.1016\/j.diagmicrobio.2012.04.003_bb0075","series-title":"Performance standards for antimicrobial susceptibility testing twentieth informational supplement, M100-S20","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2010"},{"key":"10.1016\/j.diagmicrobio.2012.04.003_bb0025","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1128\/JCM.02098-09","article-title":"Decreased susceptibility to teicoplanin and vancomycin in coagulase-negative staphylococci isolated from orthopedic-device-associated infections","volume":"48","author":"Cremniter","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2012.04.003_bb0010","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1128\/JCM.41.3.1219-1224.2003","article-title":"Five-test simple scheme for species-level identification of clinically significant coagulase-negative staphylococci","volume":"41","author":"De Paulis","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2012.04.003_bb0050","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1128\/AAC.01641-07","article-title":"Comparative surveillance study of telavancin activity against recently collected Gram-positive clinical isolates from across the United States","volume":"52","author":"Draghi","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.04.003_bb0055","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/jac\/dkn124","article-title":"In vitro activity of telavancin against recent Gram-positive clinical isolates: results of the 2004\u201305 Prospective European Surveillance Initiative","volume":"62","author":"Draghi","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.04.003_bb0040","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/AAC.49.3.1127-1134.2005","article-title":"Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus","volume":"49","author":"Higgins","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.04.003_bb0030","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1128\/AAC.00559-07","article-title":"Characterization of a daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus strain in a patient with endocarditis","volume":"51","author":"Julian","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.04.003_bb0035","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.diagmicrobio.2010.05.007","article-title":"Molecular and epidemiologic characteristics of linezolid-resistant coagulase-negative staphylococci at a tertiary care hospital","volume":"68","author":"Kosowska-Shick","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.04.003_bb0065","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1128\/AAC.01398-07","article-title":"In vitro activity of telavancin against resistant Gram-positive bacteria","volume":"52","author":"Krause","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.04.003_bb0085","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ijantimicag.2011.02.007","article-title":"Comparative in vitro activity of telavancin, vancomycin and linezolid against heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA)","volume":"37","author":"Leonard","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2012.04.003_bb0045","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/jac\/dkl235","article-title":"Comparative activity of the new lipoglycopeptide telavancin in the presence and absence of serum against 50 glycopeptide non-susceptible staphylococci and three vancomycin-resistant Staphylococcus aureus","volume":"58","author":"Leuthner","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.04.003_bb0060","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1128\/AAC.01143-09","article-title":"Antistaphylococcal activities of telavancin tested alone and in combination by time-kill assay","volume":"54","author":"Lin","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.04.003_bb0015","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev.med.59.110106.132000","article-title":"Bacterial and fungal biofilm infections","volume":"59","author":"Lynch","year":"2008","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.diagmicrobio.2012.04.003_bb0005","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1590\/S1516-31801999000400007","article-title":"Identification and medical importance of coagulase-negative staphylococci species","volume":"117","author":"Minto","year":"1999","journal-title":"Sao Paulo Med J"},{"key":"10.1016\/j.diagmicrobio.2012.04.003_bb0080","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1128\/AAC.38.9.2065","article-title":"Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology","volume":"38","author":"Pankuch","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.04.003_bb0020","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1128\/JCM.44.5.1922-1923.2006","article-title":"High prevalence of teicoplanin resistance among Staphylococcus epidermidis strains in a 5-year retrospective study","volume":"44","author":"Trueba","year":"2006","journal-title":"J Clin Microbiol"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889312001368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889312001368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T10:52:21Z","timestamp":1542970341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889312001368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0732889312001368"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2012.04.003","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}